This compound is primarily utilized in the synthesis of complex pharmaceutical agents, particularly in the development of protease inhibitors. Its structural features make it a valuable intermediate in the production of drugs targeting viral infections, including HIV and hepatitis C. The presence of the trifluorophenyl group enhances its binding affinity to specific enzyme targets, improving the efficacy of the final drug product. Additionally, the tert-butyl carbamate moiety provides stability during synthetic processes, ensuring the integrity of the compound in multi-step reactions. Its application is critical in medicinal chemistry for creating potent and selective therapeutic agents.